⏳ Fetching live dividend data...
Home › Calculator › HOLX Dividend Calculator 2026
Hologic, Inc. · NASDAQ
Price: $76.01 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in HOLX → $107.1K in 10 years · $23.97/month
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HOLX position with:
Real after-tax yield depends on where you live and how you hold HOLX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.63% | -0.17% | $263 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.24% | -0.56% | $224 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.10% | -0.70% | $210 / yr |
| 🇬🇧 UK ISA | 0% | 2.63% | -0.17% | $263 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.40% | -0.40% | $240 / yr |
| 🇨🇦 TFSA | 0% | 2.63% | -0.17% | $263 / yr |
| 🇨🇦 CA Taxable | 25% | 1.97% | -0.83% | $197 / yr |
| 🇦🇺 Super (pension) | 15% | 2.24% | -0.56% | $224 / yr |
| 🇦🇺 AU Taxable | 30% | 1.84% | -0.96% | $184 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.94% | -0.86% | $194 / yr |
| 🇫🇷 FR Taxable | 30% | 1.84% | -0.96% | $184 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
HOLX pays quarterly — 4 times per year. Next ex-div: TBD.
How HOLX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HOLX sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-04-07 | 31,409 | — | — | ||
| D-Return | 2026-04-07 | 12,490 | $40.85 | $510.2K | ||
| D-Return | 2026-04-07 | 13,971 | $40.97 | $572.4K | ||
| D-Return | 2026-04-07 | 15,387 | $45.61 | $701.8K | ||
| D-Return | 2026-04-07 | 29,002 | $56.97 | $1.65M | ||
| D-Return | 2026-04-07 | 12,509 | $68.35 | $855.0K | ||
| D-Return | 2026-04-07 | 17,831 | $71.13 | $1.27M | ||
| D-Return | 2026-04-07 | 19,327 | $74.35 | $1.44M | ||
| D-Return | 2026-04-07 | 20,056 | $71.94 | $1.44M | ||
| D-Return | 2026-04-07 | 18,698 | $79.39 | $1.48M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HOLX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Hologic, Inc. (HOLX) is currently trading at $76.01, 13% below its 52-week high. The current dividend yield is 2.63% based on an annual payout of $2.00 per share.
Hologic, Inc. (HOLX) is a healthcare stock currently trading at $76.01 with a dividend yield of 2.63%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →